{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-144456","form_type":"8-K","ticker":"NWBO","cik":"0001072379","company_name":"NORTHWEST BIOTHERAPEUTICS INC","filed_at":"2021-11-29T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.376444+00:00","generated_at":"2026-06-28T05:03:12.957342+00:00","sec_items":["1.01","2.03"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"NWBO enters $15M loan with Streeterville; conversion right tied to Phase III data","bullets":["Net proceeds of $15M from Streeterville Capital, LLC; 22-month maturity, 8% interest, 10% OID.","No payments first 8 months, then 14 equal monthly principal installments at 110% pro rata plus interest.","Lender gets springing right upon top-line data from DCVax-L Phase III to convert balance into shares at 12% discount to next private placement.","Funds will be used for ongoing business operations."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-144456","json":"https://secwatch.observer/filing/0001104659-21-144456.json","markdown":"https://secwatch.observer/filing/0001104659-21-144456.md","text":"https://secwatch.observer/filing/0001104659-21-144456.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1072379/000110465921144456/0001104659-21-144456-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1072379/000110465921144456/tm2134065d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T05:03:12.957342+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}